Recombinant modular transporters on the basis of epidermal growth factor for targeted intracellular delivery of photosensitizers

Dinara G. Gilyazova; Andrey A. Rosenkranz; Pavel V. Gulak; Vladimir G. Lunin; Olga V. Sergienko; Mikhail A. Grin; Andrey F. Mironov; Andrey B. Rubin; Alexander S. Sobolev

doi:10.1117/12.640049

7 December 2006 Recombinant modular transporters on the basis of epidermal growth factor for targeted intracellular delivery of photosensitizers

Dinara G. Gilyazova, Andrey A. Rosenkranz, Pavel V. Gulak, Vladimir G. Lunin, Olga V. Sergienko, Mikhail A. Grin, Andrey F. Mironov, Andrey B. Rubin, Alexander S. Sobolev

Author Affiliations +

Proceedings Volume 5973, Current Research on Laser Use in Oncology: 2000-2004; 59730E (2006) https://doi.org/10.1117/12.640049
Event: Current Research on Laser Use in Oncology: 2000-2004, 2004, Moscow, Russian Federation

Abstract

The search for new pharmaceuticals has raised interest in locally-acting drugs which act over short distances within the cell, and for which different cell compartments have different sensitivities. Thus, photosensitizers used in anti-cancer therapy should be transported to the most sensitive subcellular compartments where their action is most pronounced. Earlier, we described the effects of bacterially expressed modular recombinant transporters for photosensitizers comprising a-melanocyte-stimulating hormone as an internalizable, cell-specific ligand, an optimized nuclear localization sequence, an Escherichia coli hemoglobin-like protein as a carrier, and an endosomolytic amphipathic polypeptide. These transporters delivered photosensitizers into the murine melanoma cells nuclei to result in cytotoxic effects 2 orders of magnitude greater than those of nonmodified photosensitizers. Here we describe new transporters possessing the same modules except for a ligand that is replaced with epidermal growth factor specific for other cancer cell types. The new transporter modules retained their functional activities within the chimera, this transporter delivered photosensitizers into the human carcinoma cells nuclei to result in photocytotoxic effects almost 3 orders of magnitude greater than those of nonmodified photosensitizers. The obtained results show that ligand modules of such transporters are interchangeable, meaning that they can be tailored for particular applications.

Citation Download Citation

Dinara G. Gilyazova, Andrey A. Rosenkranz, Pavel V. Gulak, Vladimir G. Lunin, Olga V. Sergienko, Mikhail A. Grin, Andrey F. Mironov, Andrey B. Rubin, and Alexander S. Sobolev "Recombinant modular transporters on the basis of epidermal growth factor for targeted intracellular delivery of photosensitizers", Proc. SPIE 5973, Current Research on Laser Use in Oncology: 2000-2004, 59730E (7 December 2006); https://doi.org/10.1117/12.640049

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available